Kura Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Kura Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Kura Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $6.1M, a 16.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.1M -$1.18M -16.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.4M +$3.47M +118% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.7M +$3.31M +97.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $6.99M +$3.15M +82% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $7.28M +$3M +70% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.93M -$1.79M -37.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $3.39M -$1.76M -34.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $3.84M -$1.73M -31.1% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $4.28M -$1.71M -28.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $4.72M -$724K -13.3% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $5.15M -$800K -13.4% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $5.57M -$761K -12% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $5.99M -$722K -10.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $5.44M -$1.67M -23.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $5.95M +$3.75M +170% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $6.33M +$6.1M +2607% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $6.71M +$6.35M +1780% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $7.11M +$6.63M +1390% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.2M +$1.61M +274% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $234K -$366K -61% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $357K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $477K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $588K Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $600K Jan 1, 2019 10-K 2020-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.